Recombinant Human KCNJ1 Protein，His

KCNJ1, also known as the renal outer medullary potassium channel (ROMK), is a member of the potassium ion channel family and plays a crucial role in renal physiology, particularly in potassium homeostasis and signal transduction pathways in the kidneys. Mutations in the KCNJ1 gene have been implicated in a rare genetic disorder called Bartter syndrome, characterized by hypokalemia, metabolic alkalosis, and increased renin and aldosterone levels, leading to electrolyte imbalances. The study of KCNJ1 recombinant proteins is essential for understanding the structure-function relationships of this channel, its physiological role in the nephron, and its interactions with various pharmacological agents. Additionally, KCNJ1 is a potential target for drug development aimed at treating conditions related to potassium imbalance and other renal pathologies. Research into its recombinant expression allows for detailed biophysical and biochemical characterization, which is necessary for deciphering the dynamics of ion conduction and the mechanisms underlying its regulation. Understanding how mutations affect KCNJ1 function can also provide insights into the disease mechanisms of Bartter syndrome and guide therapeutic strategies. Therefore, KCNJ1 recombinant proteins serve as a critical tool in both basic and applied research, enhancing our comprehension of kidney function and paving the way for novel treatment options for related disorders.